Impact BioMedical to Begin Efficacy Testing of Pan-Coronavirus Vaccine Under New Wholly Owned Subsidiary Innate Immune, Inc.
- 2020年10月04日 14:27:00
- テクノロジー
- JCN Newswire
"Highly pathogenic human coronaviruses are continuously emerging and remain a major threat to human health,"stated Daryl Thompson, Impact BioLife's Director of Scientific Initiatives and founder of advanced research company GRDG Sciences, LLC ("GRDG"). Impact BioLife is a wholly owned subsidiary of Impact BioMedical. "Our pan-coronavirus vaccine is designed to allow us to not only protect against COVID-19, which is likely here to stay, but also allow for us to quickly respond to any outbreaks of a virus of this type in the future."
Coronaviruses are a large family of viruses and are common throughout the world. There are currently seven known human coronaviruses that can make people sick. Common human coronaviruses, including types 229E, NL63, OC43, and HKU1, usually cause mild to moderate upper-respiratory tract illnesses, while MERS-CoV, SARS-CoV, and now SARS-CoV2 can cause more severe pulmonary diseases.
"COVID-19 has already cost more than one million lives and continues to disrupt the $133 trillion global economy,"commented Jason Grady, COO of DSS. "A successful pan-coronavirus vaccine could save countless lives while lessening or even preventing the types of disruptions we have seen this year that have impacted nearly everyone on the planet."
Innate Immune's orally delivered pan-coronavirus vaccine has a well demonstrated safety profile and is designed to quickly be scaled for global distribution, ease of manufacturing, and high degree of stability. Innate Immune has gathered a globally recognized team of virologists to complete the research necessary to bring this vaccine to market.
"The need for a solution to COVID-19 and potential future human coronaviruses is clear. We believe this vaccine can provide that solution while remaining economically affordable, ensuring availability across the globe"stated Chan Heng Fai, Chairman of DSS.
GRDG's Chief Scientific Advisor Dr. Roscoe M. Moore, Jr., the former United States Assistant Surgeon General and former Epidemic Intelligence Service Officer at Centers for Disease Control and Prevention or CDC commented, "This pan-coronavirus vaccine is designed to boost a human's innate ability to fight viruses such as SARS-CoV2 by activating all phases of the human immune system. If successful, it could allow us to prevent further deaths and global economic disruptions from coronaviruses."
GRDG is a specialized research team that focuses on developing solutions for biodefense under the guidelines of the Project BioShield Act, Event 201, and Potomac Institute for Policy Studies.
GRDG performs rapid analysis and research by using advanced algorithms and the most complete databases in the world. The team operates in a lean and efficient manner and when necessary utilizes the top contract research organizations to deliver solid results that are robust and accurate.
About Impact BioMedical, Inc.
Impact BioMedical, Inc. ("Impact BioMedical") is a wholly owned subsidiary of DSS. Impact BioMedical strives to leverage its scientific know-how and intellectual property rights to provide solutions that have been plaguing the biomedical field for decades. By tapping into the scientific expertise of GRDG Sciences, LLC, Impact BioMedical pledges to undertake a concerted effort in the R&D, drug discovery and development for the prevention, inhibition, and treatment of neurological, oncological and immuno related diseases. For more information on Impact BioMedical visit http://impbio.com/.
About Document Security Systems, Inc.
DSS is a multinational company operating businesses focused on brand protection technology, blockchain security, direct marketing, healthcare, real estate, and securitized digital assets. Its business model is based on a distribution sharing system in which shareholders will receive shares in its subsidiaries as DSS strategically spins them out into IPOs. Its historic business revolves around counterfeit deterrent and authentication technologies, smart packaging, and consumer product engagement. DSS is led by its Chairman and largest shareholder, Mr. Fai Chan, a highly successful global business veteran of more than 40 years specializing in corporate transformation while managing risk. He has successfully restructured more than 35 corporations with a combined value of $25 billion. For more information on DSS visit http://www.dsssecure.com.
Investor Contact:
Dave Gentry, CEO
RedChip Companies Inc.
407-491-4498
Dave@redchip.com
Copyright 2020 JCN Newswire. All rights reserved. www.jcnnewswire.com
ファミマおにぎりをジョブチューンで酷評したシェフ「小林幸司」のSNSが大炎上
【ローソン「ご褒美スティックケーキぷっくりクリーム&いちご」実食レビュー】ジョブチューン2024年4月20日放送に登場の新商品
【日本ハム】プロ初完投初完封勝利の北山亘基は勉強熱心「教授」の愛称で親しまれる/アラカルト
岡田万里奈 東京の物価高嘆く「都会こわいw」「プライヤー新調できそうな額が一瞬で胃に」
【ソフトバンク】前田悠伍1イニング2失策2失点のほろ苦デビュー戦「次につなげれば」一問一答
佐川満男さん死去 元妻の伊東ゆかり「できればまた娘と3人で歌いたかった」
田中みな実「ハワイに行ったことがない」理由は…日本のある場所で「いいもん」
【広島】宇草孔基が2年ぶりアーチで同期・森下暢仁を援護「いい手応えで打てた」
【ソフトバンク】前日負傷降板の和田毅について倉野投手コーチ「来週2軍の方で。ちょっとずらす」
「イジメの温床」「番組作る才能が無い」フィフィ、バラエティー「電流ビリビリ」への私見に賛否
何があった!?「エアコン」が想定外の壊れ具合!投稿者に話を聞いた
深夜のファミリーマート徘徊、必ず入っている「フエラムネのミニチュアおもちゃ付」を探し求めた結果……
ガーシー、またも綾野剛の暴露写真でネット歓喜「この写真見て笑っちゃう」
岡本夏生(56)、1600日ぶりにブログを更新した現在が衝撃
人気セクシー女優”別人級”がらり激変ショット公開 ネット騒然「え!」「全然印象が違う!」
ユーチューバーもこう氏、元彼女・成海瑠奈について赤裸々告白
群馬県草津町冤罪事件、フリーライターの男に懲役1年の求刑がここまで話題にならない理由
玉置浩二の妻、青田典子(53)の現在がとんでもない事になっていると話題に
曙と熱愛した相原勇(52)の現在が衝撃的すぎると話題に
着替えをのぞかれて抗議する美少女フィギュアへの批判の声にアイドルが異論
何があった!?「エアコン」が想定外の壊れ具合!投稿者に話を聞いた
岡本夏生(56)、1600日ぶりにブログを更新した現在が衝撃
曙と熱愛した相原勇(52)の現在が衝撃的すぎると話題に
深夜のファミリーマート徘徊、必ず入っている「フエラムネのミニチュアおもちゃ付」を探し求めた結果……
ガーシー、佐野ひなこの暴露を示唆でネット騒然「ファンだったのに」
いなば食品のホームページが表示されない!そして「プレスリリース」もヤバすぎると話題に
ユーチューバーもこう氏、元彼女・成海瑠奈について赤裸々告白
ガーシー、またも綾野剛の暴露写真でネット歓喜「この写真見て笑っちゃう」
神田正輝「旅サラダ」冒頭いきなり”衝撃あいさつ” スタジオは騒然
玉置浩二の妻、青田典子(53)の現在がとんでもない事になっていると話題に
ファミマおにぎりをジョブチューンで酷評したシェフ「小林幸司」のSNSが大炎上
【ローソン「ご褒美スティックケーキぷっくりクリーム&いちご」実食レビュー】ジョブチューン2024年4月20日放送に登場の新商品
【日本ハム】プロ初完投初完封勝利の北山亘基は勉強熱心「教授」の愛称で親しまれる/アラカルト
岡田万里奈 東京の物価高嘆く「都会こわいw」「プライヤー新調できそうな額が一瞬で胃に」
【ソフトバンク】前田悠伍1イニング2失策2失点のほろ苦デビュー戦「次につなげれば」一問一答
佐川満男さん死去 元妻の伊東ゆかり「できればまた娘と3人で歌いたかった」
田中みな実「ハワイに行ったことがない」理由は…日本のある場所で「いいもん」
【広島】宇草孔基が2年ぶりアーチで同期・森下暢仁を援護「いい手応えで打てた」
【ソフトバンク】前日負傷降板の和田毅について倉野投手コーチ「来週2軍の方で。ちょっとずらす」
「イジメの温床」「番組作る才能が無い」フィフィ、バラエティー「電流ビリビリ」への私見に賛否